InvestorsHub Logo

misiu143

06/25/21 10:21 AM

#171956 RE: stockorus #171955

We know that the poorer efficacy , the bigger size in the study is needed..
This is why BP they all have big number of patients in their studies and still showing minimal efficacy , and they ALL getting approve.

Go figure.

All IMO.